Two_CD
glucocorticoid_NN
binding_NN
sites_NNS
on_IN
the_DT
human_JJ
glucocorticoid_NN
receptor_NN
._.

Glucocorticoids_NNS
are_VBP
known_VBN
to_TO
have_VB
a_DT
lytic_JJ
effect_NN
in_IN
leukemic_JJ
cells_NNS
via_IN
interactions_NNS
with_IN
the_DT
glucocorticoid_NN
receptor_NN
-LRB-_-LRB-
GR_NN
-RRB-_-RRB-
._.

Cortisol_NN
and_CC
various_JJ
synthetic_JJ
glucocorticoids_NNS
bind_VBP
to_TO
the_DT
GR_NN
with_IN
one-site_JJ
kinetics_NNS
._.

Cortivazol_NN
-LRB-_-LRB-
CVZ_NN
-RRB-_-RRB-
is_VBZ
a_DT
unique_JJ
,_,
high_JJ
potency_NN
synthetic_JJ
glucocorticoid_NN
,_,
which_WDT
has_VBZ
a_DT
phenylpyrazol_NN
fused_VBN
to_TO
the_DT
A-ring_NN
of_IN
the_DT
steroid_NN
nucleus_NN
and_CC
displays_VBZ
binding_NN
consistent_JJ
with_IN
two_CD
or_CC
more_JJR
sites_NNS
in_IN
the_DT
cytosol_NN
from_IN
CEM_NN
C7_NN
cells_NNS
-LRB-_-LRB-
a_DT
human_JJ
acute_JJ
lymphoblastic_JJ
T-cell_NN
line_NN
-RRB-_-RRB-
._.

It_PRP
has_VBZ
previously_RB
been_VBN
shown_VBN
that_IN
the_DT
lower_JJR
affinity_NN
class_NN
of_IN
sites_NNS
are_VBP
similar_JJ
in_IN
affinity_NN
and_CC
site_NN
molarity_NN
to_TO
those_DT
recognized_VBN
by_IN
dexamethasone_NN
._.

The_DT
higher_JJR
affinity_NN
sites_NNS
bind_VBP
CVZ_NN
with_IN
20_CD
-_:
to_TO
50-fold_RB
greater_JJR
affinity_NN
,_,
consistent_JJ
with_IN
CVZ_NN
's_POS
enhanced_VBN
biological_JJ
effects_NNS
._.

In_IN
mutant_JJ
leukemic_JJ
cells_NNS
resistant_JJ
to_TO
the_DT
lytic_JJ
effects_NNS
of_IN
dexamethasone_NN
,_,
CVZ_NN
both_CC
lyses_VBZ
the_DT
cells_NNS
and_CC
recognizes_VBZ
a_DT
single_JJ
class_NN
of_IN
sites_NNS
similar_JJ
to_TO
the_DT
high_JJ
affinity_NN
site_NN
in_IN
CEM_NN
C7_NN
cells_NNS
._.

We_PRP
have_VBP
carried_VBN
out_RP
experiments_NNS
to_TO
define_VB
the_DT
nature_NN
of_IN
the_DT
higher_JJR
affinity_NN
CVZ_NN
binding_NN
site_NN
._.

We_PRP
now_RB
show_VBP
that_IN
:_:
1_LS
-RRB-_-RRB-
CVZ_NN
has_VBZ
more_JJR
than_IN
one_CD
binding_VBG
site_NN
in_IN
a_DT
second_JJ
,_,
independent_JJ
,_,
B-cell_NN
line_NN
,_,
IM-9_NN
;_:
2_LS
-RRB-_-RRB-
the_DT
antiglucocorticoid_JJ
RU_NN
38486_CD
is_VBZ
able_JJ
to_TO
block_VB
both_CC
CVZ_NN
's_POS
higher_JJR
and_CC
lower_JJR
affinity_NN
sites_NNS
;_:
3_LS
-RRB-_-RRB-
all_DT
of_IN
CVZ_NN
's_POS
binding_VBG
sites_NNS
are_VBP
on_IN
a_DT
protein_NN
immunologically_RB
indistinguishable_JJ
from_IN
the_DT
human_JJ
GR_NN
;_:
and_CC
4_LS
-RRB-_-RRB-
freshly_RB
isolated_VBN
clones_NNS
of_IN
CVZ-resistant_JJ
cells_NNS
have_VBP
lost_VBN
all_DT
binding_VBG
sites_NNS
for_IN
CVZ_NN
._.

These_DT
data_NNS
indicate_VBP
that_IN
CVZ_NN
is_VBZ
recognizing_VBG
two_CD
glucocorticoid_NN
binding_NN
sites_NNS
on_IN
the_DT
human_JJ
GR_NN
or_CC
a_DT
protein_NN
very_RB
similar_JJ
to_TO
it_PRP
._.

